REGISTERED
on 09 Jan 2024
Last Applicant/ Owned by
Dublin 2 D02 T380
IE
Serial Number
79348606 filed on 07th Apr 2022
Registration Number
7265337 registered on 09th Jan 2024
Correspondent Address
Mark M. Friedman
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
NEURACTHELLE
Medical apparatus, devices and instruments *for accessing subcutaneous structures of the human body for the purpose of administering medical treatment;* apparatus for drug administration, *namely, drug delivery catheters;* devices for use in the administration of pharmaceuticals, namely, implantable drug delivery ports; controlled rate release apparatus for dispensing pharmaceutical substances, *n Read More
Classification Information
Class [010]
Medical Instrument Products
Medical apparatus, devices and instruments *for accessing subcutaneous structures of the human body for the purpose of administering medical treatment;* apparatus for drug administration, *namely, drug delivery catheters;* devices for use in the administration of pharmaceuticals, namely, implantable drug delivery ports; controlled rate release apparatus for dispensing pharmaceutical substances, *namely, implantable drug delivery pumps;* medical fluid injectors; injection syringes; medical syringes; implantable subcutaneous drug delivery *ports and pumps*
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceuticals *for the prevention and treatment of neurological, endocrinological, and degenerative disorders;* pharmaceutical drugs *for the prevention and treatment of epidermal problems, and damaged skin and tissue;* pharmaceutical products for endocrine, neuroendocrine, systemic, inflammatory, and acute disorders such as sepsis, shock, haemorrhagic shock, acute bleeding disorders, and chronic disorders requiring prevention, curative or palliative treatment where no other treatments are effective or safe; pharmaceutical preparations *for the prevention and treatment of viral, metabolic, genetic, endocrine, musculoskeletal, ophthalmic, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders;* pharmaceuticals used for cerebrovascular accidents *in the nature of strokes;* pharmaceutical preparations for the prevention and treatment of arterial ischemic strokes; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases; cardiovascular drugs for use in treating hypertension; cardiovascular preparations *for the prevention and treatment of cardiometabolic conditions;* cardiovascular pharmaceuticals *for the prevention and treatment of ischemic syndromes;* cardiovascular pharmaceutical preparations *for the prevention and treatment of cardiomyopathies;* cardiovascular agents for medical purposes; cardiovascular drugs used in treating *cardiogenic shocks;* cardiovascular drugs used in myocardial infarctions; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in angina pectoris; cardiovascular drugs used in treating congestive heart failure (CHF); pharmaceutical preparations containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated sun care preparations, namely, sun tanning preparations for pharmaceutical purposes containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; *dermatologicals, namely, dermatological preparations, dermatological pharmaceutical substances, dermatological pharmaceutical products;* medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated *skin care* creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; *medicated chemical and biological skin care preparations and chemical reagents* for medical purposes which contain analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; *drug afamelanotide in aqueous and gel formulations;* pharmaceutical implants *comprising living tissue;* subcutaneous implants containing *living tissue and also containing* afamelanotide; implantable *subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the prevention and treatment of neurological, endocrinological, and degenerative disorders; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations and containing afamelanotide for the prevention and treatment of skin related diseases and disorder*
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [003]
Cosmetics and Cleaning Products
Non-medicated cosmetics; cosmetics for protecting against light and UV; cosmetics, namely, cosmetic products as leave-on, lotions, creams, ointments and other formulations as well as cosmetic products for topical use; non-medicated *skin care* preparations for protecting the skin against light and UV; non-medicated skin *care* photoprotection preparations; *non-medicated* sun care preparations for cosmetic use; sun-tanning preparations; *cosmetic* suntan lotions; suntan oils *for cosmetic purposes;* tanning gels; cosmetic preparations for skin care containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic preparations for tanning the skin without sunlight containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun screen preparations; cosmetic preparations for protecting the skin from the sun's rays; cosmetics for protecting the skin from sunburn; sun protecting creams; sun *block preparations;* sun block; sun blocking preparations; sun-block lotions; sun blocking oils; SPF sun block sprays; *lip balm with sun block;* sun blocking lipsticks; *cosmetic sunscreen preparations;* waterproof sunscreen *preparations;* water-resistant sunscreen *preparations;* sunscreen preparations; sunscreen creams; sunscreen lotions; sunscreen sticks; cosmetic foams containing sunscreen *preparations; sunscreen* preparations for protecting the hair from the sun; *non-medicated cosmetic preparations against sunburns;* non-medicated *sun care preparations* for skin care after exposure to the sun's rays.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79348606
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 8217/6
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Jul 2024 | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED |
| 14th Jul 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 26th Jun 2024 | CORRECTION UNDER SECTION 7 - PROCESSED |
| 26th Jun 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 24th Jun 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 24th Jun 2024 | FINAL DISPOSITION PROCESSED |
| 09th Apr 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 09th Jan 2024 | REGISTERED-PRINCIPAL REGISTER |
| 09th Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th Oct 2023 | NOTIFICATION PROCESSED BY IB |